Rivastigmine for minor visual hallucinations in Parkinson's disease: A randomized controlled trial with 24 months follow‐up

by Tom J. M. vanMierlo, Elisabeth M. J. Foncke, Bart Post, Ben A. Schmand, Bastiaan R. Bloem, Barbera vanHarten, Gerrit Tissingh, Alexander G. Munts, Rob J. deHaan, Rob M. A. deBie, other individuals of the CHEVAL Study Group
Published 2021-08-01